Insempra: Funding, Investors & Team (Sep 2026)
Insempra is a biotechnology company that offers businesses the opportunity to revamp their ingredient lists with high-quality products created in partnership with nature. Traditionally, companies have heavily relied on petrochemicals and harmful practices that have harmed the environment and depleted natural resources. However, with the growing concerns over environmental issues, changing consumer preferences, and stricter regulations, there is a significant shift towards sustainable ingredients in industries like beauty, personal care, food, nutrition, and fashion. Insempra's advanced technology platform allows for the production of superior natural ingredients on a large scale, assisting leading brands in transforming their products to meet these new demands. Our goal is to work together towards a more sustainable future.
Insempra has raised $21.6M across 2 funding rounds on record, the most recent a Series A of $20.0M announced in May 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Insempra Company Profile and Key Stats
Latest funding round on record: May 2024.
Insempra Funding Rounds
Insempra raised $1.6M in an undisclosed round announced in Nov 2023.
6 months later, a Series A of $20.0M was announced in May 2024.
Insempra Founders and Leadership Team
Contact details for the Insempra team: 1 of 1 has an email address on file.
Start 14-day free trial →Insempra Funding Compared to Other Biotechnology Startups
Insempra's latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Insempra in Biotechnology and Planegg
Companies Similar to Insempra
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Insempra Funding FAQs
What does Insempra do?
Insempra is a biotechnology company that offers businesses the opportunity to revamp their ingredient lists with high-quality products created in partnership with nature. Traditionally, companies have heavily relied on petrochemicals and harmful practices that have harmed the environment and depleted natural resources. However, with the growing concerns over environmental issues, changing consumer preferences, and stricter regulations, there is a significant shift towards sustainable ingredients in industries like beauty, personal care, food, nutrition, and fashion. Insempra's advanced technology platform allows for the production of superior natural ingredients on a large scale, assisting leading brands in transforming their products to meet these new demands. Our goal is to work together towards a more sustainable future.
How much funding has Insempra raised?
Insempra has raised $21.6M across 2 rounds on record. The most recent is a Series A of $20.0M announced in May 2024.
When did Insempra last raise funding?
Insempra's most recent funding round on record is a Series A of $20.0M, announced in May 2024.
Who founded Insempra?
FundedIQ lists Jens Klein (Founder) at Insempra.
Where is Insempra headquartered?
Insempra is based in Planegg, Bayern, Germany.
How many employees does Insempra have?
Insempra is in the 11-50 employee band.
How does Insempra's funding compare to other Biotechnology startups?
Insempra's latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Insempra Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Insempra is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.